Heart failure with normal ejection fraction clinical trials
63 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)
- Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
- EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)
- Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
- Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
- AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- ELEVATE-HFpEF Clinical Study
- A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
- SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
- LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
- Tailored Exercise Training Study Among Adults With HFpEF
- Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
- Novel Approaches for Improving Vascular Function in Veterans With HFpEF
- PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
- Leg Heat Therapy in Heart Failure With Preserved Ejection Fraction
- Matching Perfusion and Metabolic Activity in HFpEF
- Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
- Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
- Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- Imaging Histone Deacetylase in the Heart
- A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
- Alleviant ALLAY-HF Study
- A Preliminary Study for INFORMED
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
- Precision Rehabilitation for Veterans With (HFpEF)
- Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
- A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
- Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Purinergic Signaling and the Postmenopausal Heart
- HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
- Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
- Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
- Exercise Intolerance in Heart Failure
- WISE CVD - Continuation (WISE HFpEF)
- New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
- The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
- Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
- New Orleans Pulmonary Hypertension Biobank
- Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
- Ketogenic Diet vs Mixed Diet in Patients With Heart Failure
- Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
- MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction
- BOOST: Blended Onsite and Offsite Structured Exercise Training and Coaching
- Muscle Blood Flow Regulation in HFpEF
- Transitions of Care Clinic (TOCC)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Heart failure with normal ejection fraction” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.